ConductScience.org, home

Paper2203263

State-of-the-art conference on azidothymidine therapy for early HIV infection.

Am J Med, 1990. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. State-of-the-art conference on azidothymidine therapy for early HIV infection. Papers, record 2203263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2203263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
State-of-the-art conference on azidothymidine therapy for early HIV infection.
PubMed
Journal
Am J Med
PubMed
Year
1990
PubMed
Publication types
Clinical Trial, Consensus Statement, Consensus Development Conference, NIH, Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2026-01-28
PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
ZidovudineMajor topic
Clinical Protocols
Clinical Trials as Topic
Humans
United States

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
31249451Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.World J Gastroenterol2019https://conductscience.org/library/papers/31249451PubMed
9517872Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.Eur J Epidemiol1998https://conductscience.org/library/papers/9517872PubMed
8481217Zidovudine toxicity. Clinical features and management.Drug Saf1993https://conductscience.org/library/papers/8481217PubMed
8328771Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8328771PubMed
7730946Receipt of recommended medical care in HIV-infected and at-risk persons.J Gen Intern Med1995https://conductscience.org/library/papers/7730946PubMed
1437921Infectious diseases and AIDS.Postgrad Med J1992https://conductscience.org/library/papers/1437921PubMed
1362588The ambulatory care of HIV-infected persons: a survey of physician practice patterns.J Gen Intern Med1992https://conductscience.org/library/papers/1362588PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2203263

GET https://conductscience.org/api/papers/v1/2203263/authors